Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04654910 · ClinicalTrials.gov registry record · NA

PROMIS and Patient Satisfaction

A NA study, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
275
Enrollment target

NCT04654910: Completed NA study, sponsored by University of Rochester.

NCT04654910 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 275 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04654910, a NA study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
275 participants
Enrollment target

Study Summary

The primary aim for this study is to determine if patient satisfaction and experience is improved with the active discussion/inclusion of PROMIS scores during new foot and ankle clinic patient visits.

Primary Outcome

PROMIS® (Patient-Reported Outcomes Measurement Information System) is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children. It can be used with the general population and with individuals living with chronic conditions. Scores are typically between 20-80, but may be 0-100. Any result with higher a higher number is indicating higher pain interference effect.

Interventions

  • BEHAVIORAL Placebo
  • BEHAVIORAL PROMIS Score Explanation

Trial Details

FieldValue
Enrollment Target 275 participants
Start Date 2021-02-24
Est. Completion 2021-12-01
Phase NA
University of Rochester

636 total trials

What the finished NCT04654910 record still lists

NCT04654910 is an interventional study that assigns participants to a tested intervention. The registered 275 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT04654910 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04654910 about?

NCT04654910 is a clinical study titled "PROMIS and Patient Satisfaction". The primary aim for this study is to determine if patient satisfaction and experience is improved with the active discussion/inclusion of PROMIS scores during new foot and ankle clinic patient visits.

What is the current status of trial NCT04654910?

This trial is currently completed. It is a NA study. The enrollment target is 275 participants. The study started on 2021-02-24. Estimated completion is 2021-12-01.

What interventions are being tested in trial NCT04654910?

The interventions under investigation include: Placebo (BEHAVIORAL), PROMIS Score Explanation (BEHAVIORAL).

Who is sponsoring clinical trial NCT04654910?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04654910's enrollment target sits among peer trials

275 383rd of 2000 higher than 1,616 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01269190 · 275 participants · NA

    Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery

  • NCT01900132 · 275 participants · NA

    Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers

  • NCT04104776 · 275 participants · Phase 1

    A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

  • NCT04765150 · 275 participants

    Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04654910, the US trial registry maintained by the National Library of Medicine. NCT04654910 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.